Shanghai Cell Therapy Group

company

About

Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.

  • 251 - 500

Details

Last Funding Type
Series D
Last Funding Money Raised
¥500M
Industries
Biotechnology,Therapeutics
Founded date
Nov 29, 2013
Number Of Employee
251 - 500
Operating Status
Active

Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥1.70B
Shanghai Cell Therapy Group has raised a total of ¥1.70B in funding over 2 rounds. Their latest funding was raised on Mar 24, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 24, 2021 Series D ¥500M 1 Detail
Dec 18, 2018 Series C ¥0.92B 1 China Industrial Asset Management Detail
Nov 26, 2018 Series C ¥275M 1 China Industrial Asset Management Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Shanghai Cell Therapy Group is funded by 2 investors. China Industrial Asset Management and Jiuzhou Venture are the most recent investors.
Investor Name Lead Investor Funding Round
China Industrial Asset Management Yes Series C
Jiuzhou Venture Series D